Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1420000,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1420000/?format=api",
    "text_counter": 53,
    "type": "other",
    "speaker_name": "",
    "speaker_title": "",
    "speaker": null,
    "content": "Mr. Speaker, Sir, I also rise pursuant to Standing Order No. 53 (1) to seek a Statement on behalf of Sen. Mumma from the Standing Committee on Health regarding emergent concerns regarding the safety, profile, efficacy, and known adverse effects of the Messenger Ribonucleic Acid (mRNA) COVID-19 vaccines. In the statement, the committee should- (1) Report on the different types of COVID-19 vaccines that have been and are currently officially authorized for use in Kenya, highlighting such relevant procurement specifics for each series of vaccines, such as the authorized suppliers procured aggregate quantities of each series of vaccines and corresponding aggregate costs. Further, provide a summary outline of the distribution of the various series of vaccines across the counties in Kenya. (2) Indicate whether the Ministry of Health has sanctioned a nationwide comprehensive research on the safety, profile, efficacy, and known adverse effects of the various vaccines sanctioned for use in Kenya, and state the principle findings of the research, giving the justification for continual financial investment in the acquisition of these vaccines. (3) Provide the latest data and statistics on the number of people in Kenya who have received the mRNA COVID-19 vaccines as well as details on the current nationwide stockpile of mRNA COVID-19 vaccines. Further specifying what adverse effects and deaths have been reported nationally connected to the mRNA COVID-19 vaccines and specifically address imagined global concerns over serious harm and deaths potentially associated with experimental mRNA COVID-19 vaccines. (4) Outline any steps and measures, the Ministry of Health and the Pharmacy and Poisons Board (PPB) have taken to guarantee the health and safety of Kenyans in relation to the vaccines, specifically the measures taken to investigate and publicize, reported and observed adverse effects and finally. (5) State the Kenyan position on the continued administration of the vaccine amidst escalating global concerns and mounting evidence regarding their use. I thank you, Mr. Speaker, Sir."
}